Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Yanqiao Ren"'
Autor:
Yanqiao Ren, Licheng Zhu, Yusheng Guo, Jinqiang Ma, Lian Yang, Chuansheng Zheng, Xiangjun Dong
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 8, Pp 100942- (2024)
The hypoxic microenvironment and inflammatory state of residual tumors caused by insufficient radiofrequency ablation (iRFA) are major reasons for rapid tumor progression and pose challenges for immunotherapy. We retrospectively analyzed the clinical
Externí odkaz:
https://doaj.org/article/1af2eb747ded44d58ba5329bf3c973f4
Publikováno v:
Cancer Control, Vol 31 (2024)
Purpose To evaluate the efficacy and safety of transarterial chemoembolization (TACE) combined with regorafenib (hereafter, TACE-regorafenib) or camrelizumab (hereafter, TACE-camrelizumab) for treating hepatocellular carcinoma (HCC) with untreatable
Externí odkaz:
https://doaj.org/article/ccbfbece054b4117a9f2d8c8cbd0b1b0
Autor:
Yusheng Guo, Hebing Chen, Jiayu Wan, Yanqiao Ren, Feihong Wu, Lei Chen, Tao Sun, Lian Yang, Chuansheng Zheng
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Recently, the efficacy of two low-invasive treatments, ablation, and radiotherapy, has been fully compared for the patients with the early-stage hepatocellular carcinoma (HCC). However, the comparison between radiotherapy plus ablation and a
Externí odkaz:
https://doaj.org/article/73deb8d4988e420ebb33cc46b76593a6
Autor:
Tao Sun, Yusheng Guo, Bo Sun, Lei Chen, Yanqiao Ren, Licheng Zhu, Lijie Zhang, Yiming Liu, Chuansheng Zheng
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-8 (2023)
Abstract Objective To evaluate whether the pretreatment Lung Immune Prognostic Index (LIPI) is associated with outcomes in advanced hepatocellular carcinoma (HCC) patients under ICI. Methods A two-center retrospective study of patients with HCC treat
Externí odkaz:
https://doaj.org/article/f925b97a8d1a4480ae4cc7908261dfcc
Autor:
Xiangjun Dong, Jiacheng Liu, Yaowei Bai, Xiaoming Liu, Jinqiang Ma, Binqian Zhou, Yanqiao Ren, Chuansheng Zheng
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e25824- (2024)
As recommended by Baveno VII consensus, the utilization of pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) has been considered as standard therapeutic approach for the management of acute variceal bleeding (AVB) associated with cirr
Externí odkaz:
https://doaj.org/article/3f8ca4dfc2194b4d9ad0ef81134f51ad
Autor:
Xiangjun Dong, Ziqian Peng, Yanqiao Ren, Lei Chen, Tao Sun, Yangbo Su, Huimin Liang, Chuansheng Zheng
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Objectives The purpose of this study was to evaluate the therapeutic efficacy and safety of endovascular treatment aorto-iliac occlusive disease (AIOD) with TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions. In addition, 10
Externí odkaz:
https://doaj.org/article/30ffa80d31f44c74bb9ae88645f732a8
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Although numerous studies have reported the association between sarcopenia and the prognosis of hepatocellular carcinoma (HCC) patients, there is lack of a newer and more comprehensive meta-analysis. Herein, a comprehensive literature search
Externí odkaz:
https://doaj.org/article/8cc852c86346428483f76578205bd7d1
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Objective This research aimed to evaluate the feasibility of a novel liquid embolic agent Pickering gel emulsion of lipiodol (PGEL) for renal and hepatic artery embolization in the rabbit experimental model. Methods Embolization was performe
Externí odkaz:
https://doaj.org/article/d61719ae0e354081a23095c6a275913b
Autor:
Bin Chai, Dongqiao Xiang, Wei Wang, Yanqiao Ren, Fuquan Wang, Jihua Wang, Guofeng Zhou, Chuansheng Zheng
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Arterial enhancement fraction (AEF), derived from triphasic CT scans, is considered to indirectly reflect the ratio of hepatic arterial perfusion to total perfusion. The purpose of this study was to retrospectively investigate the
Externí odkaz:
https://doaj.org/article/d0f9600902ca428eba351adb569c1642
Autor:
Licheng Zhu, Yu Lei, Jia Huang, Yahang An, Yanqiao Ren, Lei Chen, Huangxuan Zhao, Chuansheng Zheng
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Hepatocellular carcinoma (HCC) is a highly refractory cancer and the fourth leading cause of cancer-related mortality worldwide. Despite the development of a detailed treatment strategy for HCC, the survival rate remains unsatisfactory. Oncolytic vir
Externí odkaz:
https://doaj.org/article/6bbffde86eca4441a53605b4aa08f0b8